Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Kiora Pharmaceuticals, Inc. (KPRX) had Operating Cash Flow per Share of $2.56 for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-3.41M |
|
-- |
|
-- |
|
$3.60M |
|
$-3.60M |
|
$0.19M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.60M |
|
$-3.50M |
|
4.21M |
|
4.21M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$31.65M |
|
$0.06M |
|
$6.86M |
|
$38.51M |
|
$3.53M |
|
-- |
|
$4.95M |
|
$8.48M |
|
$30.03M |
|
$23.34M |
|
$30.03M |
|
3.00M |
|
| Cash Flow Statement Financials | |
$10.81M |
|
$-23.15M |
|
$15.50M |
|
$2.46M |
|
$5.64M |
|
$3.18M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$10.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.37% |
|
-14.62% |
|
-8.86% |
|
-11.37% |
|
$10.01 |
|
$2.55 |
|
|
Operating Cash Flow per Share |
$2.56 |